Renovaro's Genetically Engineered Dendritic Cell Therapy Shows Potent Anti-Tumor Efficacy in Preclinical Study

Renovaro Biosciences announced the publication of a peer-reviewed study in *Vaccines* demonstrating the significant anti-tumor efficacy of its next-ge...
Home/KnloSights/Clinical Trial Updates/Renovaro's Genetically Engineered Dendritic Cell Therapy Shows Potent Anti-Tumor Efficacy in Preclinical Study